Shots:

• Bora acquires GSK’s facility located in Mississauga- Ontario (Canada) which produces ~50 products and employs ~400 skilled manufacturing staff. The transaction is expected to be completed in H2’20
• As per the transaction- GSK’s staff will join the Bora which will continue to manufacture the existing GSK’s product line for a minimum of five years. The facility will move to a new location within a timeframe- following the closure of the transaction
• The acquisition will boost Bora’ technical capabilities & enables it to locally support its core markets of North America and Asia

Click here ­to­ read full press release/ article 

Ref: Bora Pharmaceutical | Image: ­GSK